最新报道:180 Life Sciences has secured $4.25 million in a private placement to fund its Ethereum treasury strategy, aiming to leverage blockchain technology for corporate finance innovation. The biotech firm plans to use the proceeds to explore decentralized finance (DeFi) solutions, including yield-generating protocols and tokenized assets, while maintaining its core focus on developing therapies for inflammatory diseases. The move reflects growing interest among traditional companies in integrating Web3 technologies into their financial operations.